Opioid addiction and associated cognitive damage: Inhibition by intranasal mesenchymal stem cell secretome administration
Más información
Fecha de publicación: | 2020 |
Objetivos: | We hypothesize that the non-invasive intranasal administration to opioid-addict rats of secretome derived from preconditioned MSCs will (i) reduce voluntary chronic opioid intake; (ii) inhibit opioid relapse and (iii) prevent cognitive disabilities associated to chronic opioid intake. |
Instrumento: | FONDECYT |
Año de Inicio/Término: | 2020-2004 |
Financiamiento/Sponsor: | CONICYT |
Rol del Usuario: | COINVESTIGADOR(A) |
DOI: |
1200287 |